BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28826308)

  • 21. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.
    Marteinsdottir M; Paganetti H
    Phys Med Biol; 2019 Jun; 64(11):115027. PubMed ID: 31082810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
    Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
    Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
    [No Abstract]   [Full Text] [Related]  

  • 24. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization.
    Tommasino F; Widesott L; Fracchiolla F; Lorentini S; Righetto R; Algranati C; Scifoni E; Dionisi F; Scartoni D; Amelio D; Cianchetti M; Schwarz M; Amichetti M; Farace P
    Phys Med Biol; 2020 Feb; 65(4):045002. PubMed ID: 31851957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
    Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
    Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
    Knäusl B; Fuchs H; Dieckmann K; Georg D
    Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperfractionated intensity-modulated proton therapy for pharyngeal cancer with variable relative biological effectiveness: A simulation study.
    Kasamatsu K; Matsuura T; Yasuda K; Miyazaki K; Takao S; Tamura M; Otsuka M; Uchinami Y; Aoyama H
    Med Phys; 2022 Dec; 49(12):7815-7825. PubMed ID: 36300598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
    Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
    Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion.
    Fuchs H; Alber M; Schreiner T; Georg D
    Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal tissue sparing potential of scanned proton beams with and without respiratory gating for the treatment of internal mammary nodes in breast cancer radiotherapy.
    Dasu A; Flejmer AM; Edvardsson A; Witt Nyström P
    Phys Med; 2018 Aug; 52():81-85. PubMed ID: 30139613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
    Wedenberg M; Toma-Dasu I
    Med Phys; 2014 Sep; 41(9):091706. PubMed ID: 25186381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of potentially variable RBE in liver proton therapy.
    Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
    Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
    Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.